Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sylvia A van Laar"'
Autor:
Hanieh Abedian Kalkhoran, Juliëtte Zwaveling, Bert N. Storm, Sylvia A. van Laar, Johanneke EA Portielje, Henk Codrington, Dieuwke Luijten, Pepijn Brocken, Egbert F. Smit, Loes E. Visser
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background This study was designed to investigate the impact of age on the effectiveness and immune-related adverse events (irAEs) of programmed death-(ligand)1 [PD-(L)1] inhibitors in patients with non-small cell lung cancer (NSCLC) using a
Externí odkaz:
https://doaj.org/article/6e2c3adabad54791a0cd2e967e1b62e7
Autor:
Sylvia A. van Laar, Ellen Kapiteijn, Kim B. Gombert-Handoko, Henk-Jan Guchelaar, Juliette Zwaveling
Publikováno v:
Cancers, 14(21). MDPI
Cancers; Volume 14; Issue 21; Pages: 5426
Cancers; Volume 14; Issue 21; Pages: 5426
Simple Summary: Recently, nivolumab, pembrolizumab, both immune-checkpoint inhibitors (ICIs) and the combination of dabrafenib plus trametinib (D + T) were registered as adjuvant melanoma treatments, to prevent recurrence. The aim of this paper was t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dce68d2ce9191090dcbe5983f06f630
https://doi.org/10.3390/cancers14215426
https://doi.org/10.3390/cancers14215426
Publikováno v:
Clinical Pharmacology and Therapeutics
Clinical Pharmacology & Therapeutics, 108(3), 644-652. WILEY
Clinical Pharmacology & Therapeutics, 108(3), 644-652. WILEY
Real-world evidence can close the inferential gap between marketing authorization studies and clinical practice. However, the current standard for real-world data extraction from electronic health records (EHRs) for treatment evaluation is manual rev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71fa5dc6f98d1aa0414448135f1097a0
https://hdl.handle.net/1887/3181911
https://hdl.handle.net/1887/3181911
Autor:
Kim B. Gombert-Handoko, Marieke M. Ebbens, Patricia M. L. A. van den Bemt, Sylvia A van Laar, Elsbeth J. Wesselink
Publikováno v:
Annals of Pharmacotherapy, 52(12), 1211-1217. SAGE Publishing
Annals of Pharmacotherapy, 52(12), 1211-1217
Annals of Pharmacotherapy, 52(12), 1211-1217
Background: Pharmacy-led medication reconciliation in elective surgery patients is often performed at the preoperative screening (POS). Because of the time lag between POS and admission, changes in medication may lead to medication errors at admissio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae266a43a01982a5b2a3c8bd4dfbf098
https://pubmed.ncbi.nlm.nih.gov/29923419
https://pubmed.ncbi.nlm.nih.gov/29923419
Autor:
Abedian Kalkhoran, Hanieh1,2 (AUTHOR) h.abedian_kalkhoran@lumc.nl, Zwaveling, Juliëtte1 (AUTHOR), Storm, Bert N.2 (AUTHOR), van Laar, Sylvia A.1 (AUTHOR), Portielje, Johanneke EA3 (AUTHOR), Codrington, Henk4 (AUTHOR), Luijten, Dieuwke4 (AUTHOR), Brocken, Pepijn4 (AUTHOR), Smit, Egbert F.5 (AUTHOR), Visser, Loes E.2,6,7 (AUTHOR)
Publikováno v:
BMC Cancer. 3/14/2023, Vol. 23 Issue 1, p1-12. 12p.
Autor:
van Laar, Sylvia A., de Boer, Mark G. J., Gombert‐Handoko, Kim B., Guchelaar, Henk‐Jan, Zwaveling, Juliette
Publikováno v:
British Journal of Clinical Pharmacology; Nov2021, Vol. 87 Issue 11, p4450-4454, 5p
Autor:
van Laar, Sylvia A.1 (AUTHOR), Kapiteijn, Ellen2 (AUTHOR), Gombert-Handoko, Kim B.1 (AUTHOR), Guchelaar, Henk-Jan1 (AUTHOR), Zwaveling, Juliette1 (AUTHOR) j.zwaveling@lumc.nl
Publikováno v:
Cancers. Nov2022, Vol. 14 Issue 21, p5426. 15p.
Autor:
van Laar, Sylvia A., Gombert-Handoko, Kim B., Wassenaar, Sophie, Kroep, Judith R., Guchelaar, Henk-Jan, Zwaveling, Juliette
Publikováno v:
Supportive Care in Cancer; Nov2022, Vol. 30 Issue 11, p9181-9189, 9p
Autor:
Ebbens, Marieke M., Laar, Sylvia A. van, Wesselink, Elsbeth J., Gombert-Handoko, Kim B., van den Bemt, Patricia M. L. A.
Publikováno v:
Annals of Pharmacotherapy; Dec2018, Vol. 52 Issue 12, p1211-1217, 7p